13F-HR filed by MIRABELLA FINANCIAL SERVICES LLP
MIRABELLA FINANCIAL SERVICES LLP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-17, with 516 holding rows worth $899,135,000.
- Accession
- 0001172661-22-001498
- Filer
- CIK 1538853
- Filed
- 2022-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A combination report, 516 entries on the cover page, a total value of $899,135,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $899,135,000 with VALUE read as thousands by filing date, 13F file number 028-20053. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerHudson Bay Capital Management LP028-12909
- reports for this filerVerition Fund Management LLC028-13309
- reports for this filerGUARDIAN POINT CAPITAL, LP028-17294
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ATHENEX INC | 04685N103 | COM | 44,900 | $37,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 17,600 | $36,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 25,400 | $36,000 | thousands by filing date | |
| CARROLS RESTAURANT GROUP INC | 14574X104 | COM | 15,400 | $35,000 | thousands by filing date | |
| COMSCORE INC | 20564W105 | COM | 11,600 | $34,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 30,100 | $34,000 | thousands by filing date | |
| RIBBON COMMUNICATIONS INC | 762544104 | COMMON STOCK | 10,700 | $33,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 24,200 | $32,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 22,100 | $30,000 | thousands by filing date | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 18,800 | $29,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 09077J107 | COM | 11,416 | $28,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 20,900 | $27,000 | thousands by filing date | |
| LIVEONE INC | 53814X102 | COM | 31,300 | $26,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 11,600 | $26,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 15,400 | $22,000 | thousands by filing date | |
| MUSTANG BIO INC | 62818Q104 | COM | 12,600 | $13,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-001498 | this filing | 2022-05-17 | acceptance time not in the bulk data set |